Results 121 to 130 of about 11,634 (196)

Complications of intracoronary abciximab bolus-only versus standard protocol during percutaneous coronary intervention in acute coronary syndrome

, 2014
Muhammad Tariq Shakoor, Samia Ayub, Sajid Dhakam   +2 more
openalex   +1 more source

Antiagregantes plaquetarios: mecanismos de acción y riesgos asociados al uso Platelet antiaggregants: mechanisms of action and use asocied risks

Vitae, 2009
Las Enfermedades Cardiovasculares son la principal causa de muerte en el mundo. Junto con los esfuerzos en disminuir los factores de riesgo cardiovascular, se recurre a diversos medicamentos para disminuir la morbimortalidad asociada a estas enfermedades,
Iván F PALOMO G, Constanza I TORRES U, Rodrigo E MOORE-CARRASCO, Marcelo A ALARCÓN L, Patricio J MARAGAÑO L   +4 more
doaj  

Antiagregación y anticoagulación en síndromes coronarios agudos: niveles de evidencia [PDF]

, 2007
Management of acute coronary syndromes (ACS) has moved rapidly in parallel with our understanding of the pathophysiological basis of the disease. In the eighties, the demonstration of the pivotal role of coronary thrombosis in the etiology of a ACS led ...
Garcia, R. (R.), Paramo, J.A. (José Antonio), Rodriguez, P. (P.), Ruiz-de-Gaona, E. (Estefanía)   +3 more
core  

A Longitudinal Analysis of Outcomes Associated with Abciximab and Eptifibatide in a Consecutive Series of 3074 Percutaneous Coronary Interventions

, 2007
Kirsten Hall Long, Henry H. Ting, Erin K. McMurtry, Ryan J. Lennon, Douglas L. Wood, David R. Holmes, Ganesh Raveendran, Charanjit S. Rihal   +7 more
openalex   +1 more source

P3700Intracoronary tenecteplase versus abciximab as adjunctive treatment during primary PCI in acute myocardial infarction of anterior location [PDF]

, 2017
F. J. Morales Ponce, F.J. Lozano Cid, P. Martinez Romero, P. González Pérez, J.A. Sánchez Brotons, I. Díaz Torres, Eduardo Martínez de Morentín, I. Perez Lopez, Francisco Javier Camacho Jurado, R González, P.L. Martinez Garcia, C. Collado Moreno, Sánchez Turrión, Philippe Matéo, Ana Serrador   +14 more
openalex   +1 more source

PLATELET ANTIAGGREGANTS: MECHANISMS OF ACTION AND USE ASOCIED RISKS

Vitae, 2009
Cardiovascular diseases are the main cause of death in the world. Next to efforts to reduce the cardiovascular risk factors, several drugs are resorted to decrease morbimortality associated to these diseases: antihypertensive, antidiabetic, hypolipemiant
Iván F. PALOMO G, Constanza I. TORRES U., Rodrigo E. MOORE-Carrasco., Marcelo A. ALARCÓN L., Patricio J. MARAGAÑO L.   +4 more
doaj  

Benefits of abciximab for patients with ischemic stroke [PDF]

, 2005
Claire Braybrook
openalex   +1 more source

Evaluation of Abciximab on Dissolution of Newly Formed Thrombus Developed During Coronary Angioplasty and Stenting

, 2022
CHUAN-YU GAO, ROBERT WHITBOURN
openalex   +2 more sources

Non-traumatic spinal intradural haematoma: a rare case of paralysis following abciximab for ST elevation acute coronary syndrome [PDF]

, 2016
G. Wong, D. Scherer, Adam J. Nelson, M. Worthley   +3 more
openalex   +1 more source

Acute Profound Thrombocytopenia Secondary to Local Abciximab Infusion [PDF]

, 2012
Matthew N. Peters, Christopher Press, John Moscona, Rashad H. Khazi Syed, Morgan J. Katz, Alison A Egan, Mohannad Bisharat, Vikram S. Nijjar, Asif Anwar   +8 more
openalex   +1 more source